De Pascalis Roberto, Mittereder Lara, Chou Alicia Y, Kennett Nikki J, Elkins Karen L
Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States of America.
PLoS One. 2015 May 14;10(5):e0126570. doi: 10.1371/journal.pone.0126570. eCollection 2015.
In the last decade several new vaccines against Francisella tularensis, which causes tularemia, have been characterized in animal models. Whereas many of these vaccine candidates showed promise, it remains critical to bridge the preclinical studies to human subjects, ideally by taking advantage of correlates of protection. By combining in vitro intramacrophage LVS replication with gene expression data through multivariate analysis, we previously identified and quantified correlative T cell immune responses that discriminate vaccines of different efficacy. Further, using C57BL/6J mice, we demonstrated that the relative levels of gene expression vary according to vaccination route and between cell types from different organs. Here, we extended our studies to the analysis of T cell functions of BALB/cByJ mice to evaluate whether our approach to identify correlates of protection also applies to a Th2 dominant mouse strain. BALB/cByJ mice had higher survival rates than C57BL/6J mice when they were immunized with suboptimal vaccines and challenged. However, splenocytes derived from differentially vaccinated BALB/cByJ mice controlled LVS intramacrophage replication in vitro in a pattern that reflected the hierarchy of protection observed in C57BL/6J mice. In addition, gene expression of selected potential correlates revealed similar patterns in splenocytes of BALB/cByJ and C57BL/6J mice. The different survival patterns were related to B cell functions, not necessarily to specific antibody production, which played an important protective role in BALB/cByJ mice when vaccinated with suboptimal vaccines. Our studies therefore demonstrate the range of mechanisms that operate in the most common mouse strains used for characterization of vaccines against F. tularensis, and illustrate the complexity necessary to define a comprehensive set of correlates.
在过去十年中,针对引起兔热病的土拉弗朗西斯菌研发了几种新型疫苗,并在动物模型中对其特性进行了研究。尽管这些候选疫苗中有许多显示出了潜力,但将临床前研究成果应用于人类受试者仍然至关重要,理想情况下是利用保护相关性来实现。通过多变量分析将体外巨噬细胞内的土拉弗朗西斯菌弱毒株(LVS)复制情况与基因表达数据相结合,我们之前已识别并量化了能够区分不同效力疫苗的相关T细胞免疫反应。此外,我们利用C57BL/6J小鼠证明,基因表达的相对水平会因接种途径以及不同器官的细胞类型而异。在此,我们将研究扩展至对BALB/cByJ小鼠T细胞功能的分析,以评估我们识别保护相关性的方法是否也适用于Th2主导的小鼠品系。当用次优疫苗免疫并进行攻毒时,BALB/cByJ小鼠的存活率高于C57BL/6J小鼠。然而,来自不同接种方式的BALB/cByJ小鼠的脾细胞在体外控制LVS巨噬细胞内复制的模式,反映了在C57BL/6J小鼠中观察到的保护等级。此外,所选潜在相关性的基因表达在BALB/cByJ和C57BL/6J小鼠的脾细胞中呈现出相似的模式。不同的存活模式与B细胞功能有关,不一定与特异性抗体产生有关,当用次优疫苗接种时,B细胞功能在BALB/cByJ小鼠中发挥了重要的保护作用。因此,我们的研究证明了在用于表征抗土拉弗朗西斯菌疫苗的最常见小鼠品系中起作用的一系列机制,并说明了定义一套全面相关性所需的复杂性。